PRPO News and Press, Precipio Inc. From 05/10/22

NEW HAVEN, Conn., May 10, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announced today that American Oncology Network (AON) of Fort Myers, Florida, has completed its validation of Precipio’s proprietary IV-Cell ...

NEW HAVEN, Conn., April 26, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , is excited to announce its participation and the presentation of HemeScreen, its novel diagnostic technology platform, at the Executive War College ...

Shares of specialty cancer diagnostics company Precipio (NASDAQ:PRPO) fell 17% on Tuesday, on track to snap a three-day gaining streak, after the company held its post-earnings call Monday evening. PRPO had risen over 21% on Monday. Last week, the company had reported its FY21 results, with i...

Gainers: Sunshine Biopharma (SBFM) +132%. Dingdong Limited (DDL) +29%. System1 (SST) +27%. FG Financial Group (FGF) +25%. Missfresh (MF) +21%. BT Brands (BTBD) +20%. Longeveron (LGVN) +18%. Compass Therapeutics (CMPX) +18%. Allego (ALLG) +17%. Nam Tai Property (NTP) +15%. Losers: IMARA (IMRA)...

Gainers: Sunshine Biopharma (SBFM) +181%. Nano-X Imaging (NNOX) +15%. Arcus Biosciences (RCUS) +13%. Cue Biopharma (CUE) +11%. Dermata Therapeutics (DRMA) +6%. Losers: IMARA (IMRA) -35%. GBS (GBS) -15%. Precipio (PRPO) -13%. Cassava Sciences (SAVA) -10%...

Precipio, Inc. (PRPO) Q4 2021 Results Conference Call April 5, 2022 5:00 PM ET Company Participants Ilan Danieli - CEO Presentation Operator Welcome to the Precipio Shareholder -- Fourth Quarter 2021 Shareholder Update Conference Call. All participants will be in listen-only mode. [Operator I...

Precipio press release (NASDAQ:PRPO): FY GAAP EPS of -$0.40. Revenue of $8.85M (+45.3% Y/Y). Shares -2.38% AH. For further details see: Precipio GAAP EPS of -$0.40, revenue of $8.85M

PRPO, SRAX, SUPN For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings after Monday's close

NEW HAVEN, Conn., March 22, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , will be hosting its Q4-2021 and year end shareholder update call on Monday, April 4 th at 5:00 PM ET. The call will include updates on the Company&#x...

Precipio (NASDAQ:PRPO) said CFO Carl Iberger will resign, effective Mar. 21 for personal reasons. Matt Gage, who currently serves as director of financial reporting and analysis, has been promoted to interim CFO effective immediately. Gage joined Precipio following its acquisition of Transgen...